Taro Pharmaceutical Industries Ltd. Stock price

Equities

TARO

IL0010827181

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
42.34 USD +0.19% Intraday chart for Taro Pharmaceutical Industries Ltd. +0.02% +1.34%
Sales 2024 * 618M Sales 2025 * - Capitalization 1.59B
Net income 2024 * 41M Net income 2025 * - EV / Sales 2024 * 2.57 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * -
P/E ratio 2024 *
38.4 x
P/E ratio 2025 *
-
Employees 1,554
Yield 2024 *
-
Yield 2025 *
-
Free-Float 17.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.28%
1 week-0.17%
Current month+0.45%
1 month+0.31%
3 months+0.64%
6 months+11.80%
Current year+1.15%
More quotes
1 week
42.02
Extreme 42.02
42.39
1 month
40.45
Extreme 40.45
42.44
Current year
40.45
Extreme 40.45
45.76
1 year
22.89
Extreme 22.89
45.76
3 years
22.89
Extreme 22.89
77.22
5 years
22.89
Extreme 22.89
109.42
10 years
22.89
Extreme 22.89
173.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 16-11-30
Director of Finance/CFO 69 07-12-31
Chief Tech/Sci/R&D Officer 58 -
Members of the board TitleAgeSince
Director/Board Member 73 20-01-31
Chairman 68 10-09-21
Director/Board Member 67 10-08-31
More insiders
Date Price Change Volume
24-03-28 42.34 +0.19% 31 473
24-03-27 42.26 +0.28% 36,403
24-03-26 42.14 -0.24% 28,320
24-03-25 42.24 +0.36% 19,951
24-03-22 42.09 -0.24% 19,521

Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT

More quotes
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
42.26 USD
Average target price
43 USD
Spread / Average Target
+1.75%
Consensus
  1. Stock
  2. Equities
  3. Stock Taro Pharmaceutical Industries Ltd. - Nyse